BioCentury | Mar 28, 2018
Distillery Techniques

Drug platforms

...online March 5, 2018 doi:10.1038/nbt.4086 CONTACT: Koji Tamada, Yamaguchi University, Yamaguchi, Japan email: ktamada@yamaguchi-u.ac.jp Jennie Walters Noile-Immune Biotech Inc. Yamaguchi University Chemokine...
BioCentury | Sep 8, 2017
Company News

Takeda adds CAR T therapies

...an exclusive license to a next generation CAR T platform from Professor Koji Tamada at Yamaguchi University...
BioCentury | Sep 5, 2017
Company News

Takeda adds CAR T therapies

...the partnership. Noile-Immune has an exclusive license to a next generation CAR T platform from Yamaguchi University...
BioCentury | Jun 15, 2015
Company News

Prima BioMed, NEC, Yamaguchi University deal

...see BioCentury, Jan. 5). Prima BioMed Ltd. (ASX:PRR;NASDAQ:PBMD), Sydney, Australia NEC Corp. (Tokyo:6701), Tokyo, Japan Yamaguchi University...
Items per page:
1 - 4 of 4
BioCentury | Mar 28, 2018
Distillery Techniques

Drug platforms

...online March 5, 2018 doi:10.1038/nbt.4086 CONTACT: Koji Tamada, Yamaguchi University, Yamaguchi, Japan email: ktamada@yamaguchi-u.ac.jp Jennie Walters Noile-Immune Biotech Inc. Yamaguchi University Chemokine...
BioCentury | Sep 8, 2017
Company News

Takeda adds CAR T therapies

...an exclusive license to a next generation CAR T platform from Professor Koji Tamada at Yamaguchi University...
BioCentury | Sep 5, 2017
Company News

Takeda adds CAR T therapies

...the partnership. Noile-Immune has an exclusive license to a next generation CAR T platform from Yamaguchi University...
BioCentury | Jun 15, 2015
Company News

Prima BioMed, NEC, Yamaguchi University deal

...see BioCentury, Jan. 5). Prima BioMed Ltd. (ASX:PRR;NASDAQ:PBMD), Sydney, Australia NEC Corp. (Tokyo:6701), Tokyo, Japan Yamaguchi University...
Items per page:
1 - 4 of 4